How does hormone replacement therapy affect a woman’s risk for developing Alzheimer’s disease? Dr. Carey Gleason, a researcher at the Wisconsin Alzheimer’s Disease Research Center, joins us to offer her insight on menopausal hormone therapy and the many factors patients and their physicians should consider in the decision-making process. Guest: Carey Gleason, PhD, Clinical Psychology, Associate Professor and Researcher, Wisconsin Alzheimer’s Disease Research Center